Published in J Nucl Med on June 01, 2001
High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol (2005) 1.12
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging (2010) 0.99
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging (2008) 0.94
Contemporary adrenal scintigraphy. Eur J Nucl Med Mol Imaging (2006) 0.88
18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J Surg (2010) 0.84
Renal cell carcinoma mimicking adrenal tumor. J Oncol (2010) 0.79
Contemporary imaging of incidentally discovered adrenal masses. Nat Rev Urol (2009) 0.78
Role of molecular imaging in management of nonhypersecreting adrenal masses. J Nucl Med (2001) 0.77
Nuclear imaging to characterize adrenal tumors: Comparison with MRI. World J Radiol (2014) 0.77
Childhood adrenocortical carcinoma: Case report and review. Indian J Endocrinol Metab (2012) 0.75
Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A (2001) 4.93
Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation (1996) 4.24
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group. Lancet (1997) 2.54
Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation (1995) 2.23
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med (1997) 2.15
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med (2001) 1.70
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med (1998) 1.64
Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med (1992) 1.62
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med (1997) 1.60
Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med (1997) 1.54
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab (2001) 1.51
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
High frequency percutaneous transtracheal jet ventilation. Crit Care Med (1978) 1.45
Effects of myocardial revascularization on regional thallium-201 uptake and systolic function in regions with reverse redistribution on tomographic thallium-201 imaging at rest in patients with chronic coronary artery disease. J Nucl Cardiol (1998) 1.45
Nasotracheal jet ventilation for rigid endoscopy. Ann Thorac Surg (1994) 1.42
Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol (1992) 1.42
Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients. J Nucl Med (1989) 1.41
Pattern of left ventricular filling in hypertrophic cardiomyopathy. Assessment by Doppler echocardiography and radionuclide angiography. Eur Heart J (1998) 1.39
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res (1999) 1.38
Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol (1998) 1.38
Interactions of the borna disease virus P, N, and X proteins and their functional implications. J Biol Chem (1998) 1.31
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res (2000) 1.30
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage (2005) 1.25
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab (1999) 1.17
Splenic hypoperfusion as a sign of systemic amyloidosis. Abdom Imaging (2005) 1.12
Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation (1996) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
Characteristics, associations and outcome of partial agenesis of the corpus callosum in the fetus. Ultrasound Obstet Gynecol (2006) 1.08
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res (1994) 1.08
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart (2009) 1.07
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis. J Magn Reson Imaging (2000) 1.05
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol (1999) 1.05
High-frequency positive-pressure ventilation in management of a patient with bronchopleural fistula. Anesthesiology (1980) 1.02
Accessory thyroid in the anterior mediastinum: case report. J Nucl Med (1975) 1.02
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1996) 1.02
A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol (1993) 1.01
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation). Neurology (1996) 1.01
Mixed transcortical aphasia: clinical features and neuroanatomical correlates. A possible role of the right hemisphere. Eur Neurol (1991) 0.99
Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis. Scand J Rheumatol (2008) 0.99
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J Neurol Neurosurg Psychiatry (1988) 0.99
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology (2011) 0.98
Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol (1997) 0.97
Fluidic technology. A discussion and a description of a fluidic controlled ventilator for use with high flow oxygen techniques. Anaesthesia (1976) 0.96
Elimination of some problems encountered in total replacement of the heart with an intrathoracic mechanical pump: venous return. Trans Am Soc Artif Intern Organs (1966) 0.96
Accuracy of neurosonography and MRI in clinical management of fetuses referred with central nervous system abnormalities. Ultrasound Obstet Gynecol (2014) 0.96
Progetto ATENA, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Eur J Epidemiol (1992) 0.95
Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med (1998) 0.95
Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging. J Biomed Biotechnol (2011) 0.95
Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med (1996) 0.95
Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr (1987) 0.94
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol (1998) 0.94
Determinants of cardiac augmentation by elevations in intrathoracic pressure. J Appl Physiol (1985) (1985) 0.94
Suspended animation for delayed resuscitation. Crit Care Med (1996) 0.94
123I-iomazenil as a clinical tool for studying neuronal loss. J Am Geriatr Soc (1997) 0.93
Coracoclavicular joint: osteologic study of 1020 human clavicles. J Anat (2002) 0.92
Different patterns of technetium-99m sestamibi uptake in multiple myeloma. Eur J Nucl Med (1998) 0.92
Follow-up of patients with previous vascular interventions: role of multidetector row computed tomographic angiography of the abdominal aorta and lower extremities. J Cardiovasc Surg (Torino) (2004) 0.92
Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet (1992) 0.91
Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med (1997) 0.91
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. J Clin Endocrinol Metab (2000) 0.91
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab (2001) 0.91
Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med (1995) 0.91
Comparative diagnostic evaluation with MR cholangiopancreatography, ultrasonography and CT in patients with pancreatobiliary disease. Radiol Med (2009) 0.90
Frequency encoding for simultaneous display of multimodality images. J Nucl Med (1999) 0.90
Nuclear imaging in cancer theranostics. Q J Nucl Med Mol Imaging (2007) 0.90
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf) (2000) 0.90
Hepatic and splenic amyloidosis: dual-phase spiral CT findings. Abdom Imaging (2003) 0.90
Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf) (1998) 0.89
Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease. Br J Dermatol (2009) 0.89
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis. Mult Scler (2009) 0.89
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Neurology (2004) 0.88
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. Nucl Med Commun (2002) 0.88
Rare diffuse peritoneal malignant neoplasms: CT findings in two cases. Abdom Imaging (2004) 0.88
Unknown primary tumors. Biochim Biophys Acta (2011) 0.88
Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol (1996) 0.88
Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A. Haemophilia (2013) 0.87
Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1998) 0.87
Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med (2009) 0.87
Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol (1998) 0.87
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation. Q J Nucl Med Mol Imaging (2008) 0.86
MIBI as prognostic factor in breast cancer. Q J Nucl Med (2003) 0.86
Characterization of HuH6, Hep3B, HepG2 and HLE liver cancer cell lines by WNT/β - catenin pathway, microRNA expression and protein expression profile. Cell Mol Biol (Noisy-le-grand) (2010) 0.86
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metab (1998) 0.86
Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics. Eur J Epidemiol (1991) 0.86
Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J (1988) 0.86
Can we achieve over 100 hours' survival with a total mechanical heart? Trans Am Soc Artif Intern Organs (1971) 0.86
The many ways to myocardial perfusion imaging. Q J Nucl Med Mol Imaging (2005) 0.86
MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures. Clin Genet (2010) 0.86